Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Gratwohl, R. Brand, F. Frassoni, V. Rocha, D. Niederwieser, P. Reusser, H. Einsele, C. Cordonnier, For Transplantation (2005)
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar timeBone Marrow Transplantation, 36
J. Wingard, N. Majhail, R. Brazauskas, Zhiwei Wang, K. Sobocinski, D. Jacobsohn, M. Sorror, M. Horowitz, B. Bolwell, J. Rizzo, G. Socié (2011)
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 16
B. Savani, B. Savani, P. Stratton, A. Shenoy, Eleftheria Kozanas, S. Goodman, A. Barrett (2008)
Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 14 9
Maurizio Guida, M. Castaldi, R. Rosamilio, V. Giudice, F. Orio, C. Selleri (2016)
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an updateJournal of Ovarian Research, 9
Kolb Hj, G. Socié, T. Duell, M. Lint, A. Tichelli, J. Apperley, E. Nekolla, P. Ljungman, N. Jacobsen, M. Weel, R. Wick, M. Weiss, H. Prentice (1999)
Malignant Neoplasms in Long-Term Survivors of Bone Marrow TransplantationAnnals of Internal Medicine, 131
H. Hamoda, N. Panay, R. Arya, M. Savvas (2016)
The British Menopause Society & Women’s Health Concern 2016 recommendations on hormone replacement therapy in menopausal womenPost Reproductive Health, 22
Claire Scrivani, M. Merideth, Tajana Pulanic, S. Pavletic, R. Childs, M. Hsieh, P. Stratton (2017)
Early Diagnosis of Labial Fusion in Women After Allogeneic Hematopoietic Cell Transplant Enables Outpatient TreatmentJournal of Lower Genital Tract Disease, 21
S. Pinelli, S. Basile (2018)
Fertility Preservation: Current and Future Perspectives for Oncologic Patients at Risk for Iatrogenic Premature Ovarian InsufficiencyBioMed Research International, 2018
R. Kornik, A. Rustagi (2017)
Vulvovaginal Graft-Versus-Host Disease.Obstetrics and gynecology clinics of North America, 44 3
L. Tauchmanovà, C. Selleri, G. Rosa, A. Sammartino, C. Carlo, T. Musella, C. Martorelli, G. Lombardi, B. Rotoli, C. Nappi, A. Colao (2007)
Estrogen-progestin therapy in women after stem cell transplant: our experience and literature reviewMenopause, 14
P. Piccioni, P. Scirpa, Ilenia D'Emilio, F. Sorà, Marilisa Scarciglia, L. Laurenti, S. Matteis, S. Sica, G. Leone, P. Chiusolo (2004)
Hormonal replacement therapy after stem cell transplantation.Maturitas, 49 4
Avivi, Avraham Koren-Michowitz, Vera-Llonch, M. Oster, Hagiwara M
Measuring Therapeutic Response in Chronic Graft-versus-host-disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus- Host Disease: Iv. Response Criteria Working Group Report
S. Chiodi, S. Spinelli, P. Bruzzi, P. Anserini, C. Grazia, A. Bacigalupo (2016)
Menstrual patterns, fertility and main pregnancy outcomes after allogeneic haematopoietic stem cell transplantationJournal of Obstetrics and Gynaecology, 36
M. Dolmans, C. Marinescu, P. Saussoy, A. Langendonckt, C. Amorim, J. Donnez (2010)
Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe.Blood, 116 16
Sara Tedeschi, B. Savani, M. Jagasia, B. Engelhardt, C. Anasetti, A. Barrett, Stephanie Lee (2010)
Time to consider HPV vaccination after allogeneic stem cell transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 16 8
Agnieszka Piekarska, Sebastian Giebel, Grzegorz Basak, J. Dybko, K. Hałaburda, I. Hus, E. Karakulska-Prystupiuk, Beata Jakubas, Patrycja Mensah-Glanowska, P. Rzepecki, A. Wierzbowska, L. Gil (2017)
Szczepienia ochronne u chorych dorosłych po przeszczepieniu komórek krwiotwórczych – zalecenia sekcji do spraw zakażeń PALGActa haematologica Polonica, 48
J. Rizzo, R. Curtis, G. Socié, K. Sobocinski, E. Gilbert, O. Landgren, L. Travis, W. Travis, M. Flowers, D. Friedman, M. Horowitz, J. Wingard, H. Deeg (2009)
Solid cancers after allogeneic hematopoietic cell transplantation.Blood, 113 5
S. Spinelli, S. Chiodi, S. Costantini, M. Lint, A. Raiola, G. Ravera, A. Bacigalupo (2003)
Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.Haematologica, 88 10
A. Loren, P. Mangu, L. Beck, L. Brennan, A. Magdalinski, A. Partridge, G. Quinn, W. Wallace, K. Oktay, Anthony Magda, Nohr Beck (2013)
Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 19
B. Savani, S. Goodman, A. Barrett, J. Barrett (2009)
Can Routine Posttransplant HPV Vaccination Prevent Commonly Occurring Epithelial Cancers after Allogeneic Stem Cell Transplantation?Clinical Cancer Research, 15
Jakob Passweg, H. Baldomero, P. Bader, C. Bonini, S. Cesaro, P. Dreger, R. Duarte, C. Dufour, J. Kuball, D. Farge-Bancel, A. Gennery, N. Kröger, F. Lanza, A. Nagler, A. Sureda, M. Mohty (2016)
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyBone Marrow Transplantation, 51
D. Zantomio, Andrew Grigg, Lachlan Macgregor, Y. Panek-Hudson, Jeff Szer, R. Ayton (2006)
Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for managementBone Marrow Transplantation, 38
H. Hamoda (2017)
The British Menopause Society and Women’s Health Concern recommendations on the management of women with premature ovarian insufficiencyPost Reproductive Health, 23
P. Hirsch, M. Leclerc, M. Rybojad, A. Petropoulou, M. Robin, P. Ribaud, Régis Tour, B. Cavelier-Balloy, G. Socié, D. Vexiau-Robert (2012)
Female Genital Chronic Graft-Versus-Host Disease: Importance of Early Diagnosis to Avoid Severe ComplicationsTransplantation Journal, 93
R. Baber, N. Panay, A. Fenton (2016)
2016 IMS Recommendations on women’s midlife health and menopause hormone therapyClimacteric, 19
Christopher Chung, R. Sargent, Nadia Chung, J. Lacey, M. Wakabayashi (2016)
Graft-versus-Host Disease-Associated Vulvovaginal Symptoms after Bone Marrow Transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22 2
A. Brennan, M. Hickey (2017)
Gynaecological care after stem cell transplant: An overview.Maturitas, 105
The, 21
Eva Knutsson, Yvonne Björk, Anna-Karin Broman, L. Helström, Anne-Marie Jakobsen, O. Nilsson, K. Sundfeldt, M. Brune (2014)
Genital chronic graft-versus-host disease in females: a cross-sectional study.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20 6
A. Ciavattini, N. Clemente (2015)
Female genital tract chronic graft-versus-host disease: review of the literature.Anticancer research, 35 1
B. Tirri, P. Häusermann, H. Bertz, Hildegard Greinix, A. Lawitschka, C. Schwarze, D. Wolff, Jörg Halter, D. Dörfler, R. Moffat (2015)
Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHDBone Marrow Transplantation, 50
S. Akhtar, I. Youssef, H. Soudy, T. Elhassan, S. Rauf, I. Maghfoor (2015)
Prevalence of menstrual cycles and outcome of 50 pregnancies after high-dose chemotherapy and auto-SCT in non-Hodgkin and Hodgkin lymphoma patients younger than 40 yearsBone Marrow Transplantation, 50
Yun Wang, L. Brinch, P. Jebsen, T. Tanbo, R. Kirschner (2012)
A clinical study of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 18 5
StreszczenieTransplantacja komórek krwiotwórczych (hematopoietic cell transplantation – HCT ) jest ugruntowaną metodą leczenia zarówno nienowotworowych, jak i rozrostowych chorób układu krwiotwórczego. U kobiet wiąże się jednak z występowaniem powikłań wczesnych i późnych dotyczących układu moczowo-płciowego. Konsekwencją gonadotoksycznego postępowania przygotowawczego (chemioterapii i radioterapii) jest przedwczesne wygaśnięcie funkcji jajników. U biorczyń allogenicznych przeszczepów (allogeneic HCT, allo-HCT) dodatkowo występują powikłania związane z występowaniem przewlekłej choroby przeczep przeciw gospodarzowi (chronic graft-versus-host disease – cGvHD) w istotny sposób upośledzające jakość życia kobiet w przypadku zajęcia strefy anogenitalnej (GvHDgyn). Dodatkowo przewlekła immunosupresja sprzyja występowaniu wtórnych nowotworów układu moczowo-płciowego. Pacjentki po HCT, szczególnie obciążone cGvHD, wymagają długoletniej interdyscyplinarnej opieki, włączając opiekę ginekologiczną. W pracy przedstawiono problemy ginekologiczne pacjentek po HCT oraz zaproponowano schemat standardu opieki ginekologicznej po transplantacji na podstawie piśmiennictwa i własnych doświadczeń.
Acta Haematologica Polonica – de Gruyter
Published: May 8, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.